Company Filing History:
Years Active: 2016-2018
Title: Innovations of Jeffrey A Barbon
Introduction
Jeffrey A Barbon is an accomplished inventor based in Groton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target nerve growth factor (NGF). With a total of three patents to his name, Barbon's work has the potential to impact therapeutic approaches for various disorders.
Latest Patents
Barbon's latest patents include "Caninized anti-NGF antibodies and their use" and "Anti-NGF antibodies and their use." These patents encompass NGF binding proteins, specifically focusing on chimeric, CDR grafted, and canonized antibodies. The disclosed antibodies are useful for detecting NGF and inhibiting its activity in mammals suffering from disorders where NGF activity is detrimental.
Career Highlights
Jeffrey A Barbon is currently employed at Zoetis Belgium S.a., where he continues to innovate in the field of biotechnology. His work is characterized by a commitment to advancing medical science through the development of novel therapeutic agents.
Collaborations
Barbon collaborates with talented professionals in his field, including Susan E Lacy and Meha Chhaya. These collaborations enhance the research and development efforts at Zoetis, fostering an environment of innovation.
Conclusion
Jeffrey A Barbon's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work on anti-NGF antibodies showcases the potential for innovative therapies that can improve patient outcomes.